For example, KL-6 and SP-D have been proposed as tools to support clinical practice in some countries (e.g., Japan, China) [75] for the differential diagnosis of IPF versus other ILDs, especially when combined with radiological and functional assessments. The gene discussed is MUC1; the disease is idiopathic pulmonary fibrosis.